Panomsak Suraphan, Lewsuwan Songkiat, Eiam-Ong Somchai, Kanjanabuch Talerngsak
Division of Nephrology, Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital.
J Med Assoc Thai. 2006 Aug;89 Suppl 2:S151-6.
Hepatitis B virus (HBV)-associated glomerulonephropathy (HBV-GN) has been increasingly reported, especially in adults. In the present study, the authors investigated the clinical and histopathology features of patients who suspected HBV-GN in 24 patients and age ranging from 23 to 74 years (mean 43 years). Asymptomatic hematuria was the most common presentation (54%); followed by edema and hypertension at equal percentages of 50%. The nephrotic syndrome was presented in 43%, the nephrito-nephrotic syndrome in 3.5%. Clinically suspected rapidly progressive GN was found in 14%. Renal insufficiency was determined in 30%. The most common pathologic finding was IgA nephropathy (IgAN 29%), followed by membranous nephropathy (21%), focal segmental glomerulo sclerosis (FSGS 11%), membranoproliferative GN (11%), post-infectious GN (11%). Liver disease activity also tended to be mild or had no symptoms of hepatitis. The authors remission rates both complete and partial were 75% (higher than the usual report), notwithstanding treatment. The authors achieved a sustained complete remission in half of the patients (3 in 6 cases) treated with steroid alone and 2 out of 7 cases (28.6%) treated with anti-viral therapy. Spontaneous remission was demonstrated in 2 (1 with IgAN + FSGS, and 1 with post infectious GN) out of 6 patients (33.3%). None of the patients in both treatment groups turned to ESRD that occurred in 2 cases receiving non-specific treatment. Of note, all of the patients who received anti-viral therapy or corticosteroid and had complete follow up were in remission either complete or partial.
乙型肝炎病毒(HBV)相关性肾小球肾炎(HBV-GN)的报道日益增多,尤其是在成人中。在本研究中,作者调查了24例疑似HBV-GN患者的临床和组织病理学特征,患者年龄在23至74岁之间(平均43岁)。无症状血尿是最常见的表现(54%);其次是水肿和高血压,比例均为50%。肾病综合征的发生率为43%,肾炎-肾病综合征的发生率为3.5%。临床上疑似快速进展性肾小球肾炎的发生率为14%。肾功能不全的发生率为30%。最常见的病理表现是IgA肾病(IgAN 29%),其次是膜性肾病(21%)、局灶节段性肾小球硬化(FSGS 11%)、膜增生性肾小球肾炎(11%)、感染后肾小球肾炎(11%)。肝病活动也往往较轻或无肝炎症状。尽管进行了治疗,作者报道的完全缓解和部分缓解率为75%(高于通常报道)。作者发现,单独使用类固醇治疗的患者中有一半(6例中的3例)实现了持续完全缓解,接受抗病毒治疗的7例患者中有2例(28.6%)实现了持续完全缓解。6例患者中有2例(33.3%)出现自发缓解(1例为IgAN + FSGS,1例为感染后肾小球肾炎)。两个治疗组中均无患者发展为终末期肾病,而接受非特异性治疗的2例患者出现了终末期肾病。值得注意的是,所有接受抗病毒治疗或皮质类固醇治疗并完成随访的患者均实现了完全或部分缓解。